UAE Healthcare Sector Forecast to 2012

Product Code RCS00649
Publication Date November 2011
Publisher RNCOS
Product Type Report
Pages 95
ISBN Number not applicable
Change currency
PDF £630.00 €759 $996 BUY >
PRINT £760 €915 $1,202 BUY >
CDROM £760 €915 $1,202 BUY >
Order by fax
Ask a question about this product > Receive product alerts > Call now +44 20 7060 7474

UAE Healthcare Sector Forecast to 2012

The UAE healthcare industry has shown an unprecedented growth over the past few years and is expected to continue growing in the future as well on the back of increasing population, rising prevalence of lifestyle diseases (obesity, diabetes, and hypertension), epidemic outbreaks like H1N1, and the lack of internationally accredited healthcare infrastructure.

According to our new research report, "UAE Healthcare Sector Forecast to 2012", the UAE healthcare industry is expected to sustain its growth pace in near future. The healthcare market of the UAE is expected to grow at a CAGR of over 16% during 2011-2014. The country has been witnessing tremendous increase in the demand for healthcare services and professionals, which indicates high healthcare spending. In this regard, we have done an extensive research and analysis of various segments of the UAE healthcare market, such as Hospitals Services Industry, Pharmaceutical Industry, and Medical Devices Industry.

Considering healthcare as a priority, the UAE Government is pouring the required investments and incentives to develop the healthcare infrastructure and improve the accessibility of health services for patients.

The baseline factors for the optimistic future outlook of the UAE healthcare industry includes, enhanced participation, high investments by private players, industry consolidation for medical infrastructure, and supply of pharmaceuticals. Additionally, there will be strong demand for primary healthcare level drugs, such as generics, antibiotics, and over-the-counter drugs (OTC) in the coming years as numerous drugs are on the verge of patent expiry and the UAE Government is promoting the use of generic and OTC drugs. Hence, the pharmaceutical industry is expected to grow at a CAGR of around 14.5% during 2011-2014.

Further, demand for hospitals and hospital beds is anticipated to rise over the next few years as the existing infrastructure is inadequate to deal with the rising number of health complications in all sections of the society and every age group of people. Generally, it is assumed that the developed markets average 3 beds per 1000 population, while in the UAE, it is less than 2 beds per 1000 population (in 2010), indicating a large room for future growth potential.

The report, "UAE Healthcare Sector Forecast to 2012", provides comprehensive research, objective analysis, and information on important issues of the UAE healthcare market. It studies the healthcare industry by segmenting it into hospital services, medical devices, and pharmaceuticals. The report contains statistical and analytical information on each of these segments, covering information on their market size and demand. It also features analysis of future trends, supplemented with facts and figures. In this way, the report serves as a useful guide for healthcare companies, government officials, consultants, and investors planning to enter the UAE healthcare market.

Contents

  • 1. Analyst View
  • 2. UAE Healthcare Market Overview
  • 3. Market Attractions
    • 3.1 Favorable Demographics
    • 3.2 Epidemiological Backdrop
    • 3.2.1 Diabetes
    • 3.2.2 Hypertension
    • 3.2.3 Cancer
    • 3.2.4 Infectious Diseases
    • 3.3 Health Insurance
  • 4. Emerging Market Trends
    • 4.1 Investments in Healthcare
    • 4.2 Construction of New Hospitals
    • 4.3 Consolidation in Healthcare Industry
  • 5. Hospital Services Market
    • 5.1 Hospital and Bed Capacity
    • 5.1.1 Ministry of Health
    • 5.1.2 Other Government Sector Hospitals
    • 5.1.3 Private Sector Hospitals
    • 5.2 Hospital Bed Demand Projections
  • 6. Medical Devices Market
    • 6.1 Market Trend Analysis
    • 6.2 Market Segmentation
    • 6.3 Imports and Domestic Production
    • 6.4 Regulatory Environment
  • 7. Pharmaceutical Market
    • 7.1 Market Overview
    • 7.2 Prescription and OTC Drugs
    • 7.3 Generic and Patented Drugs
    • 7.4 Imported and Domestically Manufactured Drugs
    • 7.5 Regulatory Environment
  • 8. Government Initiatives
    • 8.1 Health Programs
    • 8.2 Addressing Lack of Healthcare Professionals and Training
    • 8.3 Infrastructural Investments
    • 8.4 Industry-based Regulations
  • 9. Competitive Landscape
    • 9.1 Key Players
    • 9.1.1 Hospital Services Industry
    • 9.1.2 Pharmaceutical Industry
  • List of Figures:
    • Figure 2-1: Healthcare Market (Billion US$), 2010-2014
    • Figure 2-2: Healthcare Expenditure as Percentage of GDP (2010-2014)
    • Figure 2-3: Healthcare Expenditure by Source of Financing (%), 2008 & 2012
    • Figure 3-1: Share of Non-Emirati Population in Total Population (2010)
    • Figure 5-1: Number of Hospitals (2007 & 2008)
    • Figure 5-2: Breakup of Hospitals by Institution (%), 2008
    • Figure 5-3: Shortage of Number of Hospital Beds (2008-2010)
    • Figure 5-4: Breakup of Hospital Beds by Institution (%) 2007 & 2010
    • Figure 5-5: Number of MOH Hospital Beds (2007 & 2008)
    • Figure 5-6: Number of Private Sector Hospital Beds (2006 & 2007)
    • Figure 5-7: Demand for Number of Hospital Beds (2011-2014)
    • Figure 5-8: Shortage of Number of Doctors (2008-2010)
    • Figure 5-9: Demand for Number of Doctors (2011-2014)
    • Figure 6-1: Medical Device Market (Million US$), 2010-2014
    • Figure 6-2: Medical Device Market by Segment (%), 2010
    • Figure 6-3: Forecast for Medical Device Market by Segment (%), 2012
    • Figure 6-4: Share of Imported and Domestically Manufactured Medical Devices (2010)
    • Figure 7-1: Pharmaceutical Market (Billion US$), 2010-2014
    • Figure 7-2: Share of Prescription and OTC Drugs in Pharmaceutical Market (2010)
    • Figure 7-3: Share of Generics and Patented Drugs in Pharmaceutical Market (2010)
    • Figure 7-4: Share of Imported and Domestically Manufactured Drugs in Pharmaceutical Market (2010)
  • List of Tables:
    • Table 3-1: Demographic Characteristics (2010-2014)
    • Table 3-2: Number of Cancer Cases by Type
    • Table 3-3: Incidence of Top Infectious Diseases (2008)
    • Table 5-1: Number of MOH Hospitals by District (2008)
    • Table 5-2: Classification of MOH Hospitals by Specialty (2008)
    • Table 5-3: MOH Hospital Services to Inpatients by Specialty (2008)
    • Table 5-4: MOH Hospital Services to Outpatients by Specialty
    • Table 5-5: Number of MOH Hospital Beds by District (2008)
    • Table 5-6: Number of MOH Hospital Beds by Specialty (2008)
    • Table 5-7: Other Government Sector Hospitals by District (2008)
    • Table 5-8: Number of Other Government Sector Hospital Beds (2008)
    • Table 5-9: Private Sector Hospitals by District (2008)
    • Table 5-10: Outpatients Healthcare Facilities & Specialized Centers in Private Sector
    • Table 5-11: Private Sector Hospital Services to Patients
    • Table 5-12: Number of Private Sector Hospital Beds by District